Low Hemoglobin-to-Red Cell Distribution Width Ratio Is Associated with Disease Progression and Poor Prognosis in Upper Tract Urothelial Carcinoma

Yung-Chun Su,Sheng-Chen Wen,Ching-Chia Li,Hsiao-Chun Su,Hung-Lung Ke,Wei-Ming Li,Hsiang-Ying Lee,Chia-Yang Li,Sheau-Fang Yang,Hung-Pin Tu,Wen-Jeng Wu,Hsin-Chih Yeh
DOI: https://doi.org/10.3390/biomedicines9060672
IF: 4.757
2021-06-11
Biomedicines
Abstract:The importance of blood cell markers in patients with malignant tumors has been studied, but there are few studies on the prognostic value of hemoglobin-to-red cell distribution width ratio (HRR) in cancer. This is the first study to investigate the effect of preoperative HRR on patients with upper tract urothelial carcinoma (UTUC). Our retrospective cohort study included 730 UTUC patients who underwent nephroureterectomy from 2000 to 2019. Clinicopathological parameters were compared according to HRR levels, and the relationship between blood cell markers (HRR, white blood cell [WBC] count, platelet count) and prognosis was evaluated using Kaplan–Meier method and Cox regression model. We found that patients with HRR ≤ 1.05 tended to have worse renal function, higher pathological stages, and more high-grade tumors. In univariate analysis, HRR ≤ 1.05, WBC > 8.65 × 103 cells/μL and platelets >309 × 103 cells/μL were associated with poor progression-free survival (PFS), cancer-specific survival (CSS), and overall survival (OS). Multivariate analysis demonstrated that HRR ≤ 1.05 and WBC > 8.65 × 103 cells/μL were independent prognostic factors for predicting deterioration of PFS, CSS, and OS. In conclusion, HRR and WBC are easy to obtain in clinical practice and are useful indicators to provide prognostic information before surgery for UTUC.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the prognostic value of the low hemoglobin - to - red blood cell distribution width ratio (HRR) in patients with upper tract urothelial carcinoma (UTUC). Specifically, the study aims to evaluate the impact of preoperative HRR levels on disease progression and survival rates in UTUC patients. Through a retrospective cohort study, the authors analyzed the clinicopathological parameters of 730 UTUC patients who underwent nephroureterectomy and used the Kaplan - Meier method and Cox regression model to evaluate the relationship between blood cell markers (such as HRR, white blood cell count, platelet count) and prognosis. The study found that patients with HRR ≤1.05 tended to have poorer renal function, higher pathological stages, and more high - grade tumors. Univariate analysis showed that HRR ≤1.05, white blood cell count > 8.65 × 10^3 cells/μL, and platelet count > 309 × 10^3 cells/μL were associated with poorer progression - free survival (PFS), cancer - specific survival (CSS), and overall survival (OS). Multivariate analysis further confirmed that HRR ≤1.05 and white blood cell count > 8.65 × 10^3 cells/μL were independent prognostic factors for predicting the deterioration of PFS, CSS, and OS. In conclusion, HRR is an indicator that is easily obtainable in clinical practice and can provide valuable prognostic information for UTUC patients.